Unique cells found in lung cancer patients may predict survival
Size and number of fused cancer and immune cells linked to survival in non-small cell…
Browsing: non-small cell lung cancer
The Oncology Journal Club Episode 3: ASCO 2020 Review 1
The Oncology Podcast, brought to you by www.oncologynews.com.au, is proud to present the next episode…
ASCO 2020: Targeted therapy tepotinib for non-small cell lung cancer with MET exon 14 skipping mutation shows durable response
Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping…
ASCO 2020: Post-surgery osimertinib delays disease recurrence in patients with localised non-small cell lung cancer
Treatment with targeted therapy osimertinib following surgery for localised non-small cell lung cancer (NSCLC) with…
FDA grants accelerated approval to capmatinib for metastatic non-small cell lung cancer
The Food and Drug Administration (FDA) granted accelerated approval to capmatinib for adult patients with…
Combinations of paclitaxel and withaferin A against human non-small cell lung cancer
A paper published in Oncotarget has shown that the sensitivity of H1299 and A549 cells to concomitant…
AI may help predict responses to non-small cell lung cancer systemic therapies
Using standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC),…
Researchers identify marker that may predict whether lung cancer likely to spread
Non-small cell lung cancer (NSCLC) is the most commonly diagnosed cancer, and the leading cause…
Blood test can predict clinical response to immunotherapy in metastatic NSCLC
Non-small cell lung cancer (NSCLC) patients with higher measures of tumour mutations that show up…
Combined drug treatment for lung cancer and secondary tumours
In 20 – 40% of patients with cancer, metastasis (the development of secondary tumours) in…